In various cancer models—breast cancer cells [33], gastric cancer cells [34], medulloblastoma [35]—CUR has been shown to inhibit the Hh pathway by downregulating the expression of SHh, PTCH1, and GLI1/GLI2. Here, GLI2 is linked to cancer.